Literature DB >> 20227437

Induction of balance and breadth in the immune response is beneficial for the control of SIVmac239 replication in rhesus monkeys.

Caijun Sun1, Lei Zhang, Maochao Zhang, Yichu Liu, Miao Zhong, Xin Ma, Ling Chen.   

Abstract

OBJECTIVES: The aim of this study was to induce cellular and humoral responses with enhanced breadth and more balanced magnitude as a possible approach for an effective HIV vaccine.
METHODS: All nine of the SIVmac239 genes (gag, pol, env, nef, vif, vpx, vpr, rev and tat) were optimized for mammalian expression, synthesized and cloned into recombinant adenovirus type 5 (Ad5). These vectors were used as a vaccine regimen, and the immunogenicity and immune protection of this regimen was assessed in murine and macaques.
RESULTS: A vaccine regimen including all nine genes of the SIVmac239 virus was developed, and it was demonstrated that in contrast to single antigen vaccination, the total SIV antigen regimen more effectively elicited the balanced and broad immune responses in murine and macaques. Moreover, the responses afforded effective immune control against infection and replication of the highly pathogenic SIVmac239.
CONCLUSIONS: Induction of balance and breadth in the immune response is beneficial in controlling SIVmac239 replication in rhesus monkeys. This study provides insight for the future development of an effective HIV vaccine. 2010 The British Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20227437     DOI: 10.1016/j.jinf.2010.03.005

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  15 in total

1.  Enhancement of SIV-specific cell mediated immune responses by co-administration of soluble PD-1 and Tim-3 as molecular adjuvants in mice.

Authors:  Lijun Xiao; Dimin Wang; Caijun Sun; Pingchao Li; Yi Jin; Liqiang Feng; Ling Chen
Journal:  Hum Vaccin Immunother       Date:  2013-12-10       Impact factor: 3.452

2.  Structure-optimized dihydropyranoindole derivative GIBH-LRA002 potentially reactivated viral latency in primary CD4+ T lymphocytes of chronic HIV-1 patients.

Authors:  Qing Yang; Yuyang Ding; Fengling Feng; Enxiang Pan; Xiaozhen Fan; Xiuchang Ma; Ling Chen; Junling Zhao; Caijun Sun
Journal:  Medchemcomm       Date:  2017-07-25       Impact factor: 3.597

3.  Exacerbated AIDS Progression by PD-1 Blockade during Therapeutic Vaccination in Chronically Simian Immunodeficiency Virus-Infected Rhesus Macaques after Interruption of Antiretroviral Therapy.

Authors:  Chunxiu Wu; Yizi He; Jin Zhao; Kun Luo; Ziyu Wen; Yudi Zhang; Minchao Li; Yilan Cui; Zijian Liu; Congcong Wang; Zirong Han; Guangye Li; Fengling Feng; Pingchao Li; Ling Chen; Caijun Sun
Journal:  J Virol       Date:  2021-11-24       Impact factor: 6.549

4.  Mucosal priming with a replicating-vaccinia virus-based vaccine elicits protective immunity to simian immunodeficiency virus challenge in rhesus monkeys.

Authors:  Caijun Sun; Zhiwei Chen; Xian Tang; Yinfeng Zhang; Liqiang Feng; Yanhua Du; Lijun Xiao; Li Liu; Weijun Zhu; Ling Chen; Linqi Zhang
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

5.  Circumventing antivector immunity by using adenovirus-infected blood cells for repeated application of adenovirus-vectored vaccines: proof of concept in rhesus macaques.

Authors:  Caijun Sun; Liqiang Feng; Yinfeng Zhang; Lijun Xiao; Weiqi Pan; Chufang Li; Linqi Zhang; Ling Chen
Journal:  J Virol       Date:  2012-08-01       Impact factor: 5.103

6.  Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes.

Authors:  Wibke Bayer; Ruth Lietz; Teona Ontikatze; Lena Johrden; Matthias Tenbusch; Ghulam Nabi; Simone Schimmer; Peter Groitl; Hans Wolf; Cassandra M Berry; Klaus Uberla; Ulf Dittmer; Oliver Wildner
Journal:  Retrovirology       Date:  2011-09-26       Impact factor: 4.602

7.  Repressive effect of primary virus replication on superinfection correlated with gut-derived central memory CD4(+) T cells in SHIV-infected Chinese rhesus macaques.

Authors:  Jing Xue; Zhe Cong; Jing Xiong; Wei Wang; Hong Jiang; Ting Chen; Fangxin Wu; Kejian Liu; Aihua Su; Bin Ju; Zhiwei Chen; Marcelo A Couto; Qiang Wei; Chuan Qin
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

8.  Regulation of SIV antigen-specific CD4+ T cellular immunity via autophagosome-mediated MHC II molecule-targeting antigen presentation in mice.

Authors:  Yi Jin; Caijun Sun; Liqiang Feng; Pingchao Li; Lijun Xiao; Yizhong Ren; Dimin Wang; Chufang Li; Ling Chen
Journal:  PLoS One       Date:  2014-03-26       Impact factor: 3.240

9.  Modulation of Antiviral Immunity and Therapeutic Efficacy by 25-Hydroxycholesterol in Chronically SIV-Infected, ART-Treated Rhesus Macaques.

Authors:  Chunxiu Wu; Jin Zhao; Ruiting Li; Fengling Feng; Yizi He; Yanjun Li; Runhan Huang; Guangye Li; Heng Yang; Genhong Cheng; Ling Chen; Feng Ma; Pingchao Li; Caijun Sun
Journal:  Virol Sin       Date:  2021-05-31       Impact factor: 4.327

Review 10.  SIV infection of rhesus macaques of Chinese origin: a suitable model for HIV infection in humans.

Authors:  Yu Zhou; Rong Bao; Nancy L Haigwood; Yuri Persidsky; Wen-zhe Ho
Journal:  Retrovirology       Date:  2013-08-15       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.